G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2002
12/24/2002	US6497153 Measuring spatial variability in soil characteristics
12/24/2002	US6497150 Ultrasonic austenitic weld seam inspection method and apparatus
12/24/2002	US6497139 Method for characterizing a porous permeable medium by polarized gas NMR
12/24/2002	CA2153944C Method for the sensitive detection of nucleic acids
12/24/2002	CA2147863C Determination of peptide motifs on mhc molecules
12/24/2002	CA2070182C Chimeric immunoglobulin for cd4 receptors
12/24/2002	CA2065404C Assays and reagents for amyloid deposition
12/24/2002	CA2042093C Cell line carrying an excess of mammalian centromeres
12/19/2002	WO2002101631A1 Haplotype determination
12/19/2002	WO2002101629A1 Solution structure of il-13 and uses thereof
12/19/2002	WO2002101626A1 A method for gene mapping from chromosome and phenotype data
12/19/2002	WO2002101395A2 Rapid pharmaceutical component screening devices and methods
12/19/2002	WO2002101394A2 Screening method which uses bnpi and dnpi
12/19/2002	WO2002101393A2 Method for identifying interaction between proteins and dna fragments of a genome
12/19/2002	WO2002101392A2 Methods for treating disorders of the nervous and reproductive systems
12/19/2002	WO2002101391A2 Method of use
12/19/2002	WO2002101390A2 Method for detecting rheumatoid arthritis-specific autoantibodies
12/19/2002	WO2002101389A1 Method of assaying hyaluronic acid
12/19/2002	WO2002101388A2 Assay for predeicting cell activity
12/19/2002	WO2002101387A2 A non invasive method for screening and diagnosis fetal aneuploidies
12/19/2002	WO2002101386A1 Analytical tool
12/19/2002	WO2002101372A2 System for optimized control of multiple oxidizer feedstreams
12/19/2002	WO2002101367A2 Pipette-loaded bioassay assembly for detecting molecular or cellular events
12/19/2002	WO2002101366A1 Method for online characterisation of a moving surface and device therefor
12/19/2002	WO2002101364A1 Lipid structures and uses thereof
12/19/2002	WO2002101359A2 Integrated blood sampling analysis system with multi-use sampling module
12/19/2002	WO2002101356A2 Organellar proteomics including determination of targets for therapeutic intervention identified in the mitochondrial proteome using mass spectrometry
12/19/2002	WO2002101355A2 Improved proteomic analysis
12/19/2002	WO2002101354A2 Rapid methods for microbial typing and enumeration
12/19/2002	WO2002101353A2 Methods and products for analyzing nucleic acids based on methylation status
12/19/2002	WO2002101351A2 Method for detecting transcription factor-protein interactions
12/19/2002	WO2002101350A2 Cell migration assay
12/19/2002	WO2002101343A2 Thermal sensor for fluid detection
12/19/2002	WO2002101339A2 Imaging and analyzing parameters of small moving objects such as cells
12/19/2002	WO2002101095A1 Methods and products for analyzing nucleic acids using nick translation
12/19/2002	WO2002101092A2 Oligonucleotides for detecting hybridisation
12/19/2002	WO2002101089A2 Method for specific, fast detection of threadlike bacteria
12/19/2002	WO2002101086A2 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
12/19/2002	WO2002101084A2 Scintillation proximity assays for aminoglycoside binding molecules
12/19/2002	WO2002101083A1 Composition for detecting peptidoglycan, and diagnostic kit detecting peptidoglycan
12/19/2002	WO2002101075A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
12/19/2002	WO2002101072A2 Letm1: modulators of cellular proliferation
12/19/2002	WO2002101070A2 Alpha 2 integrin: modulators of lymphocyte activation
12/19/2002	WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	WO2002101057A1 Gene transfer into primate embryonic stem cells using vsv-g pseudo type simian immunodeficiency virus vector
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101045A2 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	WO2002101043A2 Regulation of human ta4 receptor
12/19/2002	WO2002101040A1 Human-type anti-blood coagulation factor viii antibody
12/19/2002	WO2002101037A1 Method of evaluating the function of phagocyte and utilization thereof
12/19/2002	WO2002101036A1 Method of forming stable complex of transcription product of dna encoding arbitrary peptide with translation product, nucleic acid construct to be used in the method, complex formed by the method, and screening of functional protein and mrna or dna encoding the protein using the method
12/19/2002	WO2002101035A1 Novel potential-dependent cation channel protein
12/19/2002	WO2002101034A1 Leptin-induced gene
12/19/2002	WO2002101031A1 Cyp450-specific dna probes and primers, and biological applications thereof
12/19/2002	WO2002101022A2 Method for rapid amplification of dna
12/19/2002	WO2002101018A2 Methods for inducing reversible stasis
12/19/2002	WO2002101017A2 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
12/19/2002	WO2002101015A2 Integrative assays for monitoring molecular assembly events
12/19/2002	WO2002101011A2 Reagents and methods for detection and characterization of protein-protein interactions
12/19/2002	WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100901A2 Determination of bone-sialoprotein in bodily fluids for oncological problems
12/19/2002	WO2002100897A2 Brca1/acc alpha molecular complexes, diagnostic and therapeutic applications
12/19/2002	WO2002100896A2 Method for diagnosing cancer susceptibility
12/19/2002	WO2002100892A1 Systems and methods for the analysis of proteins
12/19/2002	WO2002100890A2 Respiratory syncytial virus
12/19/2002	WO2002100883A2 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
12/19/2002	WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002	WO2002100805A2 Colorimetric nanocrystal sensors, methods of making, and use thereof
12/19/2002	WO2002100801A2 Method for reversible immobilisation of biological macromolecules and device therefor
12/19/2002	WO2002100770A2 Wafer assembly and a method for producing a wafer assembly
12/19/2002	WO2002100715A1 Underwater sampling and mapping apparatus
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100353A2 Cd10-activated prodrug compounds
12/19/2002	WO2002100349A2 Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain
12/19/2002	WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002	WO2002100337A2 Antithrombotic thrombin variants
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002	WO2002100333A2 Inhibitors of reggamma
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100276A1 Devices and methods for the expression of bodily fluids from an incision
12/19/2002	WO2002100274A1 Bodily fluid sampling device and test media cassette to be used with such a device
12/19/2002	WO2002100268A1 Method and apparatus for measuring properties of a target surface
12/19/2002	WO2002100265A2 Control solution packets and methods for calibrating fluid sampling devices
12/19/2002	WO2002100261A2 Point-of-care in-vitro blood analysis system
12/19/2002	WO2002100248A2 Compositions and methods relating to glucose metabolism, weight control, and food intake
12/19/2002	WO2002100242A2 Detection of ovarian cancer based upon alpha-haptoglobin levels
12/19/2002	WO2002100172A1 Administration of agents via the pept-2 transporter
12/19/2002	WO2002100164A1 Improvement of milk measurement and milk collection
12/19/2002	WO2002092615A3 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
12/19/2002	WO2002085937A3 Inflammation-specific peptides and the uses thereof
12/19/2002	WO2002082919B1 Detection and quantification of prion isoforms in neurodegenerative diseases using mass spectrometry
12/19/2002	WO2002082075A9 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
12/19/2002	WO2002075308A3 A kit and method for detecting food allergies
12/19/2002	WO2002074896A3 Method for analysing conditions in a container
12/19/2002	WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain

1 ... 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 ... 3937